Study on long circulating magnetoliposome entrapped paclitaxel

Chinese Pharmaceutical Journal

Volumn 38, Issue 7, 2003, Pages 520-522

  Zhang, Jing Qing ^a   Zhang, Zhi Rong ^b   Qin, Shao Rong ^a   Tan, Qun You ^a   Zhong, Guo Yao ^a   Chen, Kai Jie ^b  

^a Academy of Taiji Medical Sciences   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Liposome; Long circulating magnetoloposome; Paclitaxel

Indexed keywords

BIOMEDICAL ENGINEERING; EVAPORATION; ONCOLOGY; TISSUE CULTURE;

KIDNEYS;

DRUG PRODUCTS;

LIPOSOME; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SYNTHESIS; EVAPORATION; MOUSE; NONHUMAN; TISSUE DISTRIBUTION;

EID: 0042932591     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Fornier M, Munster P, Seidman AD. Update on the management of advanced breast cancer[J]. Oncology Huntingt. 1999, 13(5):647.
2. Babincova M. Targeted and controlled release of drugs using magnetoliposomes[J]. Ceska Slov Farm. 1999, 48(1): 27.
3. Bandak S, Goren D, Horowitz A, et al. Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models[J]. Anticancer Drugs, 1999,10(10):911.
4. Bulte JW, Cuyper M, Despres D, et al. Short-vs. long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents [J]. J Magn Reson Imaging, 1999, 9(2): 429.